Minerva Surgical (UTRS) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock UTRS vs. NMRD, MOTS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, and LUCYWShould you be buying Minerva Surgical stock or one of its competitors? The main competitors of Minerva Surgical include Nemaura Medical (NMRD), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry. Minerva Surgical vs. Its Competitors Nemaura Medical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories HeartBeam Innovative Eyewear Nemaura Medical (NASDAQ:NMRD) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment. Which has more volatility & risk, NMRD or UTRS? Nemaura Medical has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Minerva Surgical has a beta of 3.53, suggesting that its stock price is 253% more volatile than the S&P 500. Does the media refer more to NMRD or UTRS? In the previous week, Minerva Surgical had 1 more articles in the media than Nemaura Medical. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for Nemaura Medical. Nemaura Medical's average media sentiment score of 0.00 beat Minerva Surgical's score of -0.71 indicating that Nemaura Medical is being referred to more favorably in the media. Company Overall Sentiment Nemaura Medical Neutral Minerva Surgical Negative Which has better earnings and valuation, NMRD or UTRS? Nemaura Medical has higher earnings, but lower revenue than Minerva Surgical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K1.34-$14.14M-$0.390.00Minerva Surgical$51.69M0.00-$34.11MN/AN/A Do institutionals and insiders hold more shares of NMRD or UTRS? 4.4% of Nemaura Medical shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is NMRD or UTRS more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A Minerva Surgical N/A N/A N/A SummaryNemaura Medical beats Minerva Surgical on 4 of the 7 factors compared between the two stocks. Get Minerva Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTRS vs. The Competition Export to ExcelMetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$76.10M$5.66B$9.82BDividend YieldN/AN/A3.79%4.07%P/E RatioN/A10.3230.5825.12Price / SalesN/A86.76462.42114.82Price / CashN/A18.4137.4059.05Price / BookN/A7.429.096.18Net Income-$34.11M-$25.86M$3.25B$264.89M Minerva Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160Gap DownNMRDNemaura Medical1.1981 of 5 starsN/AN/A-99.7%$4K$3.02K0.0040MOTSMotus GI0.1223 of 5 starsN/AN/AN/A$1K$319K0.0030Gap DownVIVEViveve MedicalN/A$0.00flatN/A-66.7%$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.27+3.8%N/AN/A$0.00N/A0.0080News CoveragePositive NewsGap UpANZUWAnzu Special Acquisition Corp IN/A$0.04flatN/A-42.1%$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.02+38.6%N/AN/A$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.79-20.1%N/AN/A$0.00N/A0.002News CoveragePositive NewsGap DownHSCSWHeart Test LaboratoriesN/A$0.15+36.4%N/AN/A$0.00$4.35K0.0010Positive NewsGap UpBEATWHeartBeamN/A$0.26-18.6%N/A-34.8%$0.00N/A0.005Positive NewsGap DownLUCYWInnovative EyewearN/A$0.08-1.4%N/A+123.3%$0.00$1.71M0.009News CoveragePositive News Related Companies and Tools Related Companies Nemaura Medical Alternatives Motus GI Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Heart Test Laboratories Alternatives HeartBeam Alternatives Innovative Eyewear Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTRS) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access